Day: August 21, 2023

Figure 1Figure 1. JR Zone MM Lines and Proposed DDHsFigure 2Figure 2. JR Zone Long SectionFigure 3Figure 3. JR Zone Gradient IPTORONTO, Aug. 21, 2023 (GLOBE NEWSWIRE) — Copper Road Resources Inc. (TSXV: CRD) (“Copper Road” or the “Company”) is pleased to announce that the 2023 drill program has commenced at the highly-prospective JR Zone at its Copper Road Project in Batchewana Bay, Ontario. The current drill campaign is designed to demonstrate that the JR Zone hosts a shallow mineralized porphyry and high-grade breccia in the centre of the Company’s district-scale land package that hosts two past-producing copper mines. The JR Zone, comprising the Jogran Porphyry and nearby Richards Breccia (see Figure 1), is located approximately 12 km from the former Tribag Mine Zone which the Company drilled in 2022...

BILLERICA, Mass., Aug. 21, 2023 (GLOBE NEWSWIRE) — Agrify Corporation (Nasdaq: AGFY) (“Agrify” or the “Company”), a leading provider of innovative cultivation and extraction solutions for the cannabis industry, today announced that on August 16, 2023, it received a letter from the Listing Qualifications Department of the Nasdaq Stock Market LLC (“Nasdaq”) notifying Agrify that it was not in compliance with requirements of Nasdaq Listing Rule 5250(c)(1) as a result of not having timely filed its Quarterly Report on Form 10-Q for the fiscal quarter ended June 30, 2023, with the Securities and Exchange Commission (“SEC”). This notification has no immediate effect on the listing of Agrify’s common stock on the Nasdaq. However, if Agrify fails to timely regain compliance with the Nasdaq Listing Rule, Agrify’s common stock will be subject...

WATERLOO, Ontario, Aug. 21, 2023 (GLOBE NEWSWIRE) — FuelPositive Corporation (TSX.V: NHHH) (OTCQB:NHHHF) (the “Company”), a leading Green Ammonia company, announces that it has applied to the TSX Venture Exchange to amend (the “Amendment”) the terms of a series of 8,249,823 share purchase warrants (collectively, the “Warrants”). The Warrants are currently exercisable at a price of $0.34, with 3,044,000 expiring on August 21, 2023, and 5,205,823 expiring on September 5, 2023. Under the terms of the Amendment, the exercise price of the Warrants would be reduced to $0.06. As an additional incentive to encourage the exercise of the Warrants, upon exercise of each Warrant, the holder would be entitled to receive one common share and one additional share purchase warrant (each, an “Incentive Warrant”). Each Incentive Warrant will be...

STAMFORD, Conn., Aug. 21, 2023 (GLOBE NEWSWIRE) — GeneDx, a leader in delivering improved health outcomes through genomic and clinical insights, today announced that Genetics in Medicine, the official journal of the American College of Medical Genetics and Genomics (ACMG) has published a peer-reviewed research analysis resulting from a multi-lab collaboration involving GeneDx. The study, “The landscape of reported VUS in multi-gene panel and genomic testing: Time for a change,” evaluated the rate of inconclusive genetic variants, or variants of uncertain significance (VUS), reported with multi-gene panels versus exome and genome sequencing. Study findings concluded that VUS are reported more frequently on multi-gene panels (32.6%) than exome and genome sequencing (22.5%). “The high rates of VUS found with multi-gene panel tests...

PITTSBURGH, Aug. 21, 2023 (GLOBE NEWSWIRE) — Krystal Biotech, Inc. (NASDAQ: KRYS) (the “Company”), a commercial-stage biotechnology company focused on the discovery, development, and commercialization of genetic medicines to treat diseases with high unmet medical needs, announced that it has completed the sale of its Rare Pediatric Disease Priority Review Voucher (PRV) for $100 million. The Company was awarded the PRV following the U.S. Food and Drug Administration (FDA) accelerated approval of VYJUVEKTM (beremagene geperpavec-svdt) for the treatment of recessive or dominant dystrophic epidermolysis bullosa (DEB) for patients 6 months of age and older. Under the Rare Pediatric Disease Priority Review Voucher Program, the FDA awards priority review vouchers to sponsors of rare pediatric disease product applications that meet certain...

Total revenues for the second quarter of 2023 of $10.8 million, representing an 83.6% increase over the comparable period in 2022 Gross profit grew to $2.4 million, up 84.8% from $1.3 million in the comparable period in 2022. Record backlog of $20 million as of August 21, 2023 Reaffirms its previous guidance of approximately $45 million in revenue for 2023NEW YORK, NY, Aug. 21, 2023 (GLOBE NEWSWIRE) — via NewMediaWire — Applied UV, Inc. (NASDAQ: AUVI), a leader in global food security, air quality, and intelligent building solutions today announced its financial results for the second quarter 2022. For the quarter, revenues were $10.8 million, increasing 83.6%, compared with $5.9 million in the second quarter of 2022. Gross profit for the second quarter of 2023 increased to $2.4 million, up 84.8%, compared with $1.3 million...

ALACHUA, Fla. and TAMPA, Fla., Aug. 21, 2023 (GLOBE NEWSWIRE) — Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for peripheral nerve injuries, today announced the successful first week of processing for Avance Nerve Graft at the newly opened Axogen Processing Center (APC), in Dayton, Ohio. “We are pleased to mark this significant milestone as we begin processing Avance Nerve Graft in our new APC facility,” commented Karen Zaderej, Axogen’s Chairman, CEO, and President. “The APC is a world-class tissue processing center that will support our Biologics License Application (BLA) submission in the first half of 2024 and our long-term growth. The BLA will further solidify our leadership in the nerve market, as we continue to provide surgeons and their patients with improved...

Daphne Quimi to Retire At Year End PHILADELPHIA, Aug. 21, 2023 (GLOBE NEWSWIRE) — Amicus Therapeutics (Nasdaq: FOLD), a patient-dedicated global biotechnology company focused on developing and commercializing novel medicines for rare diseases, today announced that Simon Harford has been appointed Chief Financial Officer, effective immediately. Simon brings extensive financial leadership experience, having served in significant finance roles in two global pharmaceutical companies as well as most recently as a public company CFO in the biotechnology industry. Daphne Quimi has decided to retire and will remain an Amicus employee through the end of the year to ensure a smooth transition. “The Board of Directors and I offer our gratitude and best wishes to Daphne, who has made a far-reaching and positive impact on the financial strength...

American-made technology system will be used for the prototype of vehicles for government entities EUGENE, Ore., Aug. 21, 2023 (GLOBE NEWSWIRE) — Arcimoto, Inc.® (NASDAQ: FUV), makers of rightsized, ultra-efficient small footprint electric vehicles for moving people and things, today announced a partnership with MATBOCK, a veteran-owned business that designs and builds hybrid-electric tactical vehicles and innovative tactical gear, to supply the company with electrical systems architecture and energy storage systems for the development of hybrid-electric tactical vehicles. The partnership will allow MATBOCK to maintain its focus on paradigm-shifting technology by providing American-made technologies to be used by the U.S. Department of Defense in specific areas of operations. In 2022, MATBOCK launched its tactical electric vehicle...

Figure 1LAC 50 Mineralized Trend on the LUR Angilak Property, Nunavut. Yellow star indicates Main Zone drilling area.TORONTO, Aug. 21, 2023 (GLOBE NEWSWIRE) — Latitude Uranium Inc. (“Latitude Uranium”, “LUR” or the “Company”) (CSE: LUR, OTCQB: LURAF, FRA: EI1) is pleased to provide an update to shareholders in an open letter from President and CEO John Jentz. Dear Shareholders, Throughout the past year, Latitude has solidified its position as a Canadian uranium explorer and developer. With the resurgence in the nuclear sector, I am pleased to share an update on the steps we are taking to position Latitude for future success. I would also like to extend a formal welcome to our new shareholders from Valore Metals Corp (TSXV: VO). Transformative Restructuring to Latitude – Diversified and Derisked I joined Latitude Uranium...